Healthcare Industry News: mesenchymal stem cell
News Release - November 8, 2007
New Non-Surgical Stem-Cell Procedure Relieves Degenerative Joint Disease
First-of-its-kind procedure from Colorado-based companyDENVER, Nov. 8 (HSMN NewsFeed) -- Regenerative Sciences, Inc., has launched its patent-pending Regenexx(TM) procedure, which uses a patient's own stem cells to regenerate bone and cartilage -- a welcome relief for the more than 20 million Americans who suffer from painful and debilitating orthopedic conditions.
"The Regenexx procedure is different from all other treatments available today," said Chris Centeno, M.D., creator of Regenexx and an international expert and specialist in musculoskeletal, spinal and neurological injury. "Prior to Regenexx, physicians were limited in what they could offer degenerative joint patients: surgery or life with pain. Now physicians have a new tool in their tool kit."
In sanctioned clinical trials, Regenexx has been demonstrated to be safe and regenerates normal healthy tissues. A patient's stem cells are extracted with a needle from the hip, grown in culture at a Rengerative Sciences lab and then re-implanted into the patient at a doctor's office with a "needle out, needle in" approach, which substantially reduces downtime for the patient.
Unlike joint replacement or micro fracture that require weeks or months of being on crutches and pain medicines, the Regenexx procedure has no downtime. Most patients return to normal activity within 24 hours of completing the procedure.
A published clinical trial was conducted with a 46-year-old woman who had a two-year history of knee pain that began after being kicked in the shin during a martial arts class. Bone marrow was drawn from the patient, and in the next nine days, the marrow was used to grow mesenchymal stem cells, which have the ability to grow into bone, cartilage and muscle tissues. The grown stem cells initially taken from the patient were injected into her knee once a week for the next three weeks. Three months after the procedure, the patient reported that her pain had essentially disappeared. A MRI confirmed that the defect on her femur had been reduced by one-third.
Repair of the degenerated or injured area usually takes place in two to three months, and many patients feel better in one to three months.
About Regenerative Sciences
Founded in 2006, Regenerative Sciences is the Denver-based developer of Regenexx(TM), a breakthrough non-surgical option for people suffering from various orthopedic disorders. Regenexx is a patent-pending procedure that uses a person's own stem cells and blood growth factors to regenerate bone and cartilage.
The physicians at Regenerative Sciences are dedicated to providing the option of non-surgical joint repair to their patients. Headquartered in Colorado, they focus on delivering high quality treatment for people suffering from these often debilitating diseases. Visit http://www.Regenexx.com to learn more about benefits, research and the Regenexx procedure.
Source: Regenerative Sciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
